Review
Investigational drugs and research
Affiliations
- PMID: 1857767
Item in Clipboard
Review
Investigational drugs and research
Psychiatr Med.
1991.
Abstract
This chapter will define investigational use for clinicians and outline FDA policies in this area in a simple and pragmatic way. Instances in which investigational use would require application to the FDA for an investigational New Drug Exemption (IND) and instances in which their use would require approval by an Institutional Review Board (IRB) will be described and examples given.
Similar articles
-
The IRB as deputy sheriff: proposed FDA regulation of the institutional review board.Clin Res. 1979 Apr;27(2):103-8. Clin Res. 1979. PMID: 10241072 No abstract available.
-
Investigational new drug application; exception from informed consent; technical amendment--FDA. Final rule.Fed Regist. 1997 Jun 16;62(115):32479. Fed Regist. 1997. PMID: 10169828
-
Charging for investigational drugs under an investigational new drug application. Final rule.Fed Regist. 2009 Aug 13;74(155):40871-900. Fed Regist. 2009. PMID: 19691172
-
Food and Drug Administration approval process for ophthalmic drugs in the US.Curr Opin Ophthalmol. 2008 May;19(3):190-4. doi: 10.1097/ICU.0b013e3282f97fa1. Curr Opin Ophthalmol. 2008. PMID: 18408492 Review.
-
Vaccine INDs: review of clinical holds.Vaccine. 2005 Jan 19;23(9):1099-101. doi: 10.1016/j.vaccine.2004.08.038. Vaccine. 2005. PMID: 15629351 Review.